AXA (CS) · Insurance
AXA Q3 2026 earnings: summary, key numbers & outlook
Results filed 29 Oct 2026 · Quarter ended 30 Sep 2026
Press release ↗Investor relations ↗
Summaries and transcripts are machine-generated and can contain errors.
In brief
AXA's growth is led by Retail P&C, up 7% with Prima now consolidated, while AXA XL pulls back in softening commercial and reinsurance markets.
AXA's growth came mainly from Retail P&C and Health. Personal lines grew 7%, split between price increases and higher volumes, with strong Motor volumes in Europe and France. Prima, the Italian motor MGA AXA acquired a majority stake in on November 28, 2025, contributed Euro 1.0 billion. In Life, Savings, Unit-Linked and Protection all grew, and Health grew on price increases across all geographies.
Management says current trends position AXA well for "Growing Forward", its 2027–2029 strategic plan. The main tension is cycle discipline: AXA XL is shrinking in softening commercial and reinsurance markets, with pricing down, while elevated secondary-peril natural catastrophes in France, Switzerland and Italy and volatile financial markets pressure the balance sheet and the 2026 outlook.
No call transcript for this quarter, so this summary also draws on: Idéal Investisseur ↗.
Key numbers
- Gross written premiums & other revenues (9M26)
- Euro 93.0 billion
- Solvency II ratio
- 213%
up +5% vs. 9M25
down -5 points vs. June 30, 2026
| Segment or metric | Value | Change |
|---|---|---|
| Property & Casualty premiums | Euro 48.1 billion | up +3% |
| Life & Health premiums | Euro 44.8 billion | up +7% |
| Personal lines premiums | Euro 17.2 billion | up +7% |
| Commercial lines premiums | Euro 28.7 billion | up +1% |
| AXA XL Reinsurance premiums | Euro 2.2 billion | down 9% |
| Life & Health net flows | Euro +6.0 billion | vs. Euro +5.6 billion in 9M25 |
| Life & Health NB CSM (pre-tax) | Euro 1.6 billion | up +1% |
Where each number comes from
- Gross written premiums & other revenues (9M26): “Gross written premiums & other revenues1 up +5% vs. 9M25 to Euro 93.0 billion”
- Solvency II ratio: “Solvency II ratio3 at 213% as of September 30, 2026, down -5 points vs. June 30, 2026, reflecting resilience in a volatile environment”
- Property & Casualty premiums: “Property & Casualty premiums up +3% to Euro 48.1 billion”
- Life & Health premiums: “Life & Health premiums up +7% to Euro 44.8 billion, with each of Life and Health up +7%”
- Personal lines premiums: “Personal lines grew by +7% to Euro 17.2 billion, driven by:”
- Commercial lines premiums: “Commercial lines grew by +1% to Euro 28.7 billion, mainly from:”
- AXA XL Reinsurance premiums: “AXA XL Reinsurance decreased by 9% to Euro 2.2 billion, reflecting lower volumes”
- Life & Health net flows: “Net flows11 were Euro +6.0 billion, compared to Euro +5.6 billion in 9M25”
- Life & Health NB CSM (pre-tax): “NB CSM (pre-tax)1,11 increased by +1% to Euro 1.6 billion, driven by Life (+4%)”
Copied from the press release ↗ and other documents in the company's results page ↗. A figure is published only if its sentence is in those documents.
Outlook
| Metric | Period | Outlook |
|---|---|---|
| Underlying earnings | 2026 | circa Euro 8.6 billion |
| Underlying EPS growth | 2026 | top end of the plan target range of 6-8% |
| Underlying return on equity | 2026 | top end of the plan target range of 14-16% |
Key takeaways
Personal lines growth blends pricing and volume
Personal lines grew +7% to Euro 17.2 billion, with +4% from price effects and +3% from volumes. France grew +8% in both direct and proprietary agent networks, and Europe had strong Motor volume growth.
Prima adds a new MGA model
Prima contributed Euro 1.0 billion, split between Euro 0.5 billion of MGA commissions on third-party-underwritten business and Euro 0.5 billion of recaptured premiums. AXA has recaptured 31% of the premiums Prima collects, so it can keep moving more of that business onto its own balance sheet.
AXA XL deliberately shrinks in a softening market
AXA XL Insurance fell -1% with pricing down -1%, and AXA XL Reinsurance fell -9% with pricing down -5%. Management describes this as disciplined cycle management that puts profitability ahead of volume.
Life growth leans on capital-light and protection products
G/A Savings and Unit-Linked each grew +9%, and Protection grew +5% on Hong Kong and Japan sales. Net flows were Euro +6.0 billion: capital-light G/A took in Euro +1.6 billion while traditional G/A saw outflows of Euro -4.0 billion.
Health volumes strong in France, softer in Japan
Health premiums rose +7% on price effects in all geographies, and Health PVEP rose +19% on short-term business in France. Long-term Health volumes in Japan fell, pulling Health NB CSM down -12%.
Questions
What drove AXA's Property & Casualty growth this quarter?
Personal lines grew +7% to Euro 17.2 billion on a mix of price effects (+4%) and volumes (+3%), with France up +8%. Commercial lines ex-AXA XL grew +4%, while AXA XL Insurance fell -1%.
How is the Prima acquisition affecting AXA's retail business?
Prima, a majority stake completed on November 28, 2025, contributed Euro 1.0 billion to premiums. Half came from MGA commissions on business underwritten by third-party insurers and half from premiums AXA recaptured, with 31% of Prima's Euro 1.7 billion premiums recaptured so far.
Why is AXA XL shrinking?
AXA says it is managing the cycle with discipline in a softening market. AXA XL Insurance premiums fell -1% with pricing down -1%, and AXA XL Reinsurance fell -9% with pricing down -5%.
Which Life & Health products are growing fastest?
G/A Savings and Unit-Linked each rose +9%, ahead of Health and Protection. Protection led net flows at Euro +4.5 billion, helped by Hong Kong, Japan and France.
What is AXA's next strategic step?
AXA says current trends position it well for the start of "Growing Forward", its 2027–2029 strategic plan. For 2026 it expects underlying EPS growth at the top end of the plan's 6-8% range despite elevated natural catastrophe activity in Europe.
Documents
Results documents